Nelson / Woodward Sexually Transmitted Diseases

A Practical Guide for Primary Care
1. Auflage 2007
ISBN: 978-1-59745-040-9
Verlag: Humana Press
Format: PDF
Kopierschutz: 1 - PDF Watermark

E-Book, Englisch, 355 Seiten

Reihe: Current Clinical Practice

This practical guide covers the diagnosis and treatment of Sexually Transmitted Diseases (STDs) and other information critical to patient care in the new millennium. It provides the clinician with the ability to identify and manage Sexually Transmitted Infections (STIs), as well as obtain information about preventing their sequelae. Written by clinicians, this book is packed with evidence-based information steeped in years of practice.

Autoren/Hrsg.

Nelson, Anita L.

Woodward, Jo Ann

Inhaltsverzeichnis

1;Dedication;6
2;Series Editor Introduction;8
3;Foreword;9
4;Preface;11
5;Contents;13
6;1 Introduction to Sexually Transmitted Infections;17
6.1;RESOURCES;32
6.2;REFERENCES;33
7;2 Human Papillomavirus and Genital Warts;37
7.1;INTRODUCTION;37
7.2;FAST FACTS;37
7.3;PREVALENCE/INCIDENCE;38
7.4;RISK FACTORS;40
7.5;INFECTIVITY AND TRANSMISSION;40
7.6;ETIOLOGY;42
7.7;CLINICAL MANIFESTATIONS;45
7.8;TESTING FOR HPV;48
7.9;DIAGNOSIS;48
7.10;TREATMENT OF GENITAL WARTS;48
7.11;PATIENT EDUCATION AND COUNSELING;57
7.12;FOLLOW-UP;57
7.13;PARTNER NOTIFICATION AND REPORTING REQUIREMENTS;58
7.14;PREGNANCY-RELATED ISSUES;58
7.15;POTENTIAL FOR VACCINES AND OTHER PREVENTIVE MEASURES;58
7.16;CASE STUDY;59
7.17;REFERENCES;60
8;3 Genital Herpes;63
8.1;INTRODUCTION;63
8.2;FAST FACTS;63
8.3;PREVALENCE AND INCIDENCE;64
8.4;RISK FACTORS;65
8.5;INFECTIVITY AND TRANSMISSION;65
8.6;ETIOLOGY;66
8.7;CLINICAL MANIFESTATIONS;67
8.8;TESTING TECHNIQUES;71
8.9;DIAGNOSIS;74
8.10;TREATMENT;74
8.11;COUNSELING;77
8.12;PREGNANCY-RELATED ISSUES;78
8.13;PARTNER NOTIFICATION AND REPORTING REQUIREMENTS;81
8.14;PREVENTION;81
8.15;CASE STUDY;82
8.16;SELECTED RESOURCES;83
8.17;REFERENCES;84
9;4 Viral Hepatitis;87
9.1;INTRODUCTION;87
9.2;FAST FACTS;87
9.3;HEPATITIS A;88
9.4;HEPATITIS B;94
9.5;HEPATITIS C;101
9.6;OTHER FORMS OF VIRAL HEPATITIS;108
9.7;CASE STUDY;109
9.8;REFERENCES;109
10;5 HIV Infection and AIDS;115
10.1;INTRODUCTION;115
10.2;FAST FACTS;115
10.3;PREVALENCE AND INCIDENCE;116
10.4;ETIOLOGY;117
10.5;RISK FACTORS;118
10.6;CLINICAL MANIFESTATIONS;125
10.7;TESTING TECHNIQUES;126
10.8;TREATMENT;128
10.9;POSTEXPOSURE PROPHYLAXIS;129
10.10;PARTNER NOTIFICATION AND REPORTING REQUIREMENTS;132
10.11;PREGNANCY-RELATED ISSUES;132
10.12;PREVENTION;133
10.13;CONCLUSION;135
10.14;CASE STUDY;135
10.15;SELECTED RESOURCES;136
10.16;REFERENCES;136
11;6 Chlamydial Infections;142
11.1;INTRODUCTION;142
11.2;FAST FACTS;142
11.3;PREVALENCE AND INCIDENCE;143
11.4;RISK FACTORS;144
11.5;INFECTIVITY AND TRANSMISSION;144
11.6;ETIOLOGY;144
11.7;CLINICAL MANIFESTATIONS;146
11.8;TESTING TECHNIQUES;151
11.9;SCREENING RECOMMENDATIONS;156
11.10;DIAGNOSIS;157
11.11;TREATMENT;157
11.12;FOLLOW-UP;160
11.13;COMPLICATIONS OF INFECTION;161
11.14;PARTNER NOTIFICATION AND REPORTING REQUIREMENTS;161
11.15;PREGNANCY-RELATED ISSUES;161
11.16;PREVENTION;162
11.17;CASE STUDY;163
11.18;REFERENCES;163
12;7 Gonorrheal Infections;167
12.1;INTRODUCTION;167
12.2;FAST FACTS;167
12.3;PREVALENCE/INCIDENCE;167
12.4;RISK FACTORS;168
12.5;INFECTIVITY AND TRANSMISSION;168
12.6;ETIOLOGY;169
12.7;CLINICAL MANIFESTATIONS;170
12.8;TESTING AND DIAGNOSIS;177
12.9;TREATMENT;186
12.10;PARTNER NOTIFICATION AND REPORTING REQUIREMENTS;191
12.11;PREGNANCY-RELATED ISSUES;191
12.12;PREVENTION;192
12.13;CASE STUDY;192
12.14;REFERENCES;193
13;8 Upper Genital Tract Infections in Women;197
13.1;INTRODUCTION;197
13.2;FAST FACTS;197
13.3;PREVALENCE AND INCIDENCE;198
13.4;RISK FACTORS;198
13.5;ETIOLOGY;199
13.6;MICROBIOLOGY;199
13.7;INFECTIVITY AND TRANSMISSION;201
13.8;CLINICAL MANIFESTATIONS;202
13.9;TESTING TECHNIQUES;203
13.10;DIAGNOSIS;203
13.11;TREATMENT;205
13.12;PREGNANCY-RELATED ISSUES;207
13.13;PARTNER NOTIFICATION AND REPORTING REQUIREMENTS;207
13.14;FOLLOW-UP;209
13.15;RECURRENCE OF DISEASE;209
13.16;COMPLICATIONS;209
13.17;POTENTIAL FOR VACCINES AND OTHER PREVENTIVE AND/ OR THERAPEUTIC MEASURES;212
13.18;CASE STUDY;213
13.19;REFERENCES;214
14;9 Syphilis;218
14.1;INTRODUCTION;218
14.2;FAST FACTS;220
14.3;PREVALENCE AND INCIDENCE;220
14.4;RISK FACTORS;221
14.5;INFECTIVITY AND TRANSMISSION;221
14.6;ETIOLOGY;222
14.7;CLINICAL MANIFESTATIONS;223
14.8;TESTING TECHNIQUES;230
14.9;DIAGNOSIS;232
14.10;TREATMENT;233
14.11;FOLLOW-UP;235
14.12;PARTNER NOTIFICATION AND REPORTING REQUIREMENTS;236
14.13;PREGNANCY-RELATED ISSUES;236
14.14;HIV AND SYPHILIS;237
14.15;CASE STUDY;238
14.16;REFERENCES;239
15;10 Trichomoniasis;241
15.1;INTRODUCTION;241
15.2;FAST FACTS;241
15.3;PREVALENCE AND INCIDENCE;241
15.4;RISK FACTORS;242
15.5;INFECTIVITY AND TRANSMISSION;242
15.6;ETIOLOGY;242
15.7;CLINICAL MANIFESTATIONS;243
15.8;TESTING AND DIAGNOSIS;244
15.9;TREATMENT;248
15.10;PARTNER NOTIFICATION AND REPORTING REQUIREMENTS;250
15.11;PREGNANCY-RELATED ISSUES;250
15.12;PREVENTION;251
15.13;CASE STUDY;251
15.14;REFERENCES;252
16;11 Lymphogranuloma Venereum, Chancroid, Granuloma Inguinale, and Molluscum Contagiosum;254
16.1;INTRODUCTION;254
16.2;FAST FACTS;254
16.3;LYMPHOGRANULOMA VENEREUM;254
16.4;CHANCROID;260
16.5;GRANULOMA INGUINALE;266
16.6;MOLLUSCUM CONTAGIOSUM;271
16.7;CASE STUDY;274
16.8;REFERENCES;275
17;12 Ectoparasites;278
17.1;INTRODUCTION;278
17.2;FAST FACTS;278
17.3;SCABIES;279
17.4;PEDICULOSIS PUBIS;283
17.5;CASE STUDY;286
17.6;REFERENCES;287
18;13 Patient–Clinician Communication and STI Care;289
18.1;STI HISTORY: ASSESSING RISK BEHAVIOR;289
18.2;CONVEYING AN STI DIAGNOSIS;295
18.3;SUPPORTING BEHAVIOR CHANGE;299
18.4;REFERENCES;302
19;14 Cultural Competence in STI Care;304
19.1;CULTURAL CONTEXT;305
19.2;EFFECTIVE APPROACHES;309
19.3;REFERENCES;312
20;15 Effectiveness of Barrier Methods for Sexually Transmitted Infection Prevention;314
20.1;INTRODUCTION;314
20.2;FAST FACTS;314
20.3;OVERVIEW;315
20.4;MALE CONDOMS;316
20.5;CONCLUSION;325
20.6;REFERENCES;325
21;16 The Future Role of Vaccines and Microbicides;329
21.1;INTRODUCTION;329
21.2;HEPATITIS B VIRUS VACCINES;330
21.3;HUMAN PAPILLOMAVIRUS VACCINES;331
21.4;HERPES SIMPLEX VIRUS VACCINES;333
21.5;HIV VACCINES;334
21.6;(CHANCROID) VACCINES;334
21.7;(CHLAMYDIA) VACCINES;335
21.8;(GONORRHEA) VACCINES;336
21.9;(TRICHOMONIASIS) VACCINES;337
21.10;(SYPHILIS) VACCINES;338
21.11;MICROBICIDES;338
21.12;CONCLUSION;345
21.13;REFERENCES;345
22;Index;353